• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    东

    东京女子医科大学

    Tokyo Women''s Medical University
    院校EST. 1900
    1.9万论文总数
    44.1万引用总数

    论文量&引用量时间轴

    机构学者

    排序
    Teruo Okano
    Teruo Okano
    Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University;Center for Advanced Biomedical Science, Tokyo Women’s Medical University
    论文:668引用:0H-index:0
    Nobuhisa Hagiwara
    Nobuhisa Hagiwara
    Department of Internal Medicine, Tokyo Women's Medical University;Division of Cardiology, Tokyo Women's Medical University
    论文:635引用:0H-index:0
    Kosaku Nitta
    Kosaku Nitta
    Kidney Center, Department of Medicine, Faculty of Medicine, Tokyo Women's Medical University
    论文:621引用:0H-index:0
    Kazunari Tanabe
    Kazunari Tanabe
    Section of Renal Transplantation/Renovascular Surgery, Tokyo Women’s Medical University
    论文:620引用:0H-index:0
    Hisashi Yamanaka
    Hisashi Yamanaka
    Department of Rheumatology, Graduate School of Medicine, International University of Health and Welfare;Sanno Medical Center;Rheumatology Center
    论文:467引用:0H-index:0
    Takakazu Kawamata
    Takakazu Kawamata
    Department of Neurosurgery, School of Medicine, Tokyo Women’s Medical University;School of Medicine, Tokyo Women's Medical University Hospital
    论文:463引用:0H-index:0
    Hideki Ishida
    Hideki Ishida
    Department of Urology, Tokyo Women’s Medical University
    论文:416引用:0H-index:0
    Masayuki Yamato
    Masayuki Yamato
    Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University;Division of Biomedical Engineering and Science, Graduate Course of Medicine, Graduate School of Tokyo Women’s Medical University
    论文:407引用:0H-index:0
    Masakazu Yamamoto
    Masakazu Yamamoto
    Department of Surgery Institute of Gastroenterology, Tokyo Women’s Medical University
    论文:401引用:0H-index:0

    论文(10000)

    年份
    起
    –
    止
    排序
    1Attribute-based Cross-Classification Reveals Sex- and Age-Specific Prognostic Impact of Anemia in ADPKD
    Kosaku Nitta,Hiroshi Kataoka,Yusuke Ushio,Shun Manabe,Shiho Makabe, Shigeru Otsubo,Norio Hanafusa,Ken Tsuchiya,Junichi Hoshino, Toshio Mochizuki

    Anemia is less prevalent in autosomal dominant polycystic kidney disease (ADPKD) owing to preserved erythropoietin production. However, its impact on kidney prognosis remains unclear. Given sex-related differences in hemoglobin (Hb) levels, we hypothesized that the prognostic relevance of anemia may vary by sex and age. Therefore, we aimed to identify subgroup-specific risk patterns using an attribute-based cross-classification approach to support individualized anemia management in ADPKD. We analyzed 552 Japanese patients with ADPKD from a single-center cohort. The primary outcome was a ≥ 30

    2026Clinical and Experimental Nephrology(2026)引用:47
    引用
    AI阅读
    加入学术空间
    2Radiolucent Lines after Robotic-Assisted Surface-Matching Kinematically Aligned UKA: Short-Term Incidence and Lack of Association with Tibial Alignment
    Junya Itou, Ayano Kuwasawa, Kotaro Nihei,Ken Okazaki

    This study investigated the clinical outcomes of robotic-assisted unicompartmental knee arthroplasty (UKA) performed using a surface-matching kinematic technique that restores native joint morphology without alignment constraints. The primary aim was to determine the incidence and distribution of radiolucent lines (RLLs), and the secondary aim was to evaluate short-term revision rates and clinical outcomes. This retrospective cohort study reviewed 242 medial UKAs performed between November 2021 and August 2023 by the same high‑volume surgeon using a surface‑matching technique. Radiographic parameters and patient‑reported outcome measures (PROMs) obtained before and 1 year after surgery were assessed, with radiographic evaluation performed independently of the clinical outcome assessment. A cemented JOURNEY II Uni implant was used in all cases, with intraoperative surface mapping used to guide kinematic placement of components without alignment constraints. RLLs were seen in 21.9

    2026Archives of Orthopaedic and Trauma Surgery(2026)引用:43
    引用
    AI阅读
    加入学术空间
    3Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma with Liver Metastasis at Initial Diagnosis: a Nationwide Multicenter Study.
    Daisuke Hashimoto,Tsukasa Ikeura,Aya Maekawa,Takayoshi Nakajima,Keinosuke Ishido,Aoi Hayasaki,Toshimichi Asano,Masamichi Hayashi,Isaku Yoshioka,Hiromichi Ishii, Akifumi Kimura,Hideki Motobayashi,

    With recent advances in chemotherapy for unresectable pancreatic ductal adenocarcinoma (PDAC) with liver metastasis (LM), attempts have been made to resect the primary tumor in patients showing favorable responses to anti-cancer treatment (so-called “conversion surgery”; CS). This study aimed to clarify the outcomes of CS for PDAC with LM in a nationwide multicenter study. This retrospective, multicenter study was conducted as a project study of the Japan Pancreas Society and included patients with PDAC with LM at initial diagnosis, diagnosed radiologically or intraoperatively (occult LM), who underwent CS after at least 4 months of chemotherapy between 2010 and 2022. Survival outcomes and prognostic factors were analyzed. 90 patients were enrolled from 31 Japanese institutions. Median duration of preoperative chemotherapy was 10.4 (range, 4.2–58.5) months, and gemcitabine plus nab-paclitaxel was the most common first-line regimen, followed by folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin. Liver metastasectomy was performed in 27 patients (30

    2026Journal of Gastroenterology(2026)引用:35
    引用
    AI阅读
    加入学术空间
    4Increasing Proportion and More Favourable Outcomes of Seronegative Rheumatoid Arthritis: Analysis of the IORRA Cohort from 2000 to 2021
    Tomoaki Higuchi,Eiichi Tanaka,Eisuke Inoue,Eri Sugano,Katsunori Ikari,Masayoshi Harigai

    To investigate longitudinal trends in the proportion of seronegative rheumatoid arthritis (RA) and to compare clinical outcomes between seronegative and seropositive patients in a Japanese single-centre cohort. We included 4,354 RA patients with a disease duration < 4 years from the Institute of Rheumatology, Rheumatoid Arthritis cohort. Seronegativity was defined as the absence of both rheumatoid factor (RF) and anti-citrullinated peptide (CCP) antibody. We assessed the association between enrolment period and seronegativity using multivariable logistic regression. A mixed-effects model was used to compare 3-year trends in Disease Activity Score in 28 joints using erythrocyte sedimentation rate (DAS28-ESR), clinical disease activity index (CDAI), and the Japanese version of the Health Assessment Questionnaire (J-HAQ) scores between serostatus groups. The proportion of seronegative RA increased from 14.4

    2026Clinical Rheumatology(2026)引用:35
    引用
    AI阅读
    加入学术空间
    5Survival Outcomes of the Patients with Advanced Laryngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy and Total Laryngectomy Based on Reports of Head and Neck Cancer Registry of Japan
    Yuta Yamamura, Yuto Horichi,Tatsuya Furukawa,Hirotaka Shinomiya, Megumi Kitayama,Daisuke Kawakita,Takeshi Kodaira,Munenaga Nakamizo,Seiichi Yoshimoto, Ken-ichi Nibu

    Background Roles of induction chemotherapy (ICT) and chemoradiotherapy (CRT) for laryngeal preservation in patients with locally advanced laryngeal cancer (LC) remain unclear. Patients and methods We enrolled 834 patients with T3N0-2M0 and T4aN0-2M0 LC registered in the Head and Neck Cancer Registry of Japan between 2011 and 2015. Oncological outcomes of total laryngectomy (TL), CRT, and ICT were evaluated. Propensity score-matching analyses (PSMA) were performed between TL and CRT, excluding ICT. Results No significant differences were observed in overall survival (OS) and disease-specific survival (DSS) among patients treated by TL, CRT, and ICT followed by TL or CRT, and among patients treated by TL and CRT in PSMA. Of note, no significant difference was observed in LCR and LRFS between TL and ICT groups. Conclusions ICT and CRT did not yield survival benefits but might contribute to laryngeal preservation without compromising survival in patients with T3-4aN0-2M0.

    2026International Journal of Clinical Oncology(2026)引用:30
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 10000 篇论文

    合作机构(100)

    东京大学合作论文 1,245
    京都大学合作论文 811
    庆应义塾大学合作论文 805
    大阪大学合作论文 548
    九州大学合作论文 507
    顺天堂大学合作论文 476
    千叶大学合作论文 431
    东邦大学合作论文 423
    横滨市立大学合作论文 423
    东北大学(日本)合作论文 404

    机构统计